优刻得(688158) - 2024 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2024 was CNY 348,001,564.81, representing a decrease of 5.32% compared to the same period last year[4]. - The net profit attributable to shareholders was a loss of CNY 61,874,405.64, with a decrease in net profit excluding non-recurring items to CNY -62,381,553.98[5]. - The basic and diluted earnings per share were both CNY -0.14, reflecting a narrowing of losses compared to the previous year[5]. - Total operating revenue for Q1 2024 was CNY 348,001,564.81, a decrease of 5.2% compared to CNY 367,550,668.16 in Q1 2023[22]. - Net loss for Q1 2024 was CNY 62,002,253.29, an improvement from a net loss of CNY 95,796,741.13 in Q1 2023[23]. Cash Flow and Liquidity - The net cash flow from operating activities was CNY 23,174,604.94, indicating a significant cash flow generation despite the losses[5]. - The company's cash flow from operating activities showed a significant improvement, with a net cash outflow of CNY 62,097,265.31 in Q1 2024 compared to CNY 95,030,622.42 in Q1 2023[23]. - Total cash inflow from operating activities in Q1 2024 was $456,059,298.03, while cash outflow was $432,884,693.09, resulting in a positive cash flow[25]. - The ending cash and cash equivalents balance for Q1 2024 was $1,095,537,787.60, down from $1,517,590,546.30 in Q1 2023[26]. - The company’s cash outflow for taxes in Q1 2024 was $2,678,803.09, significantly lower than $5,124,024.93 in Q1 2023, reflecting improved tax efficiency[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,641,441,880.07, down 4.23% from the end of the previous year[5]. - The company's total assets decreased to CNY 3,641,441,880.07 in Q1 2024 from CNY 3,802,114,749.05 in Q1 2023[18]. - Total liabilities decreased to CNY 1,065,382,500.26 in Q1 2024 from CNY 1,163,958,103.93 in Q1 2023[18]. - The total current assets decreased to 1,772,944,677.98 RMB from 1,917,421,223.30 RMB, representing a decline of about 7.5%[16]. Expenses and Cost Management - Research and development expenses totaled CNY 48,555,376.31, accounting for 13.95% of revenue, a decrease of 1.12 percentage points from the previous year[5]. - The company reduced sales, management, and R&D expenses by CNY 18,422,600, mainly through personnel optimization and cost control measures[9]. - Research and development expenses for Q1 2024 were CNY 48,555,376.31, down from CNY 55,372,044.78 in Q1 2023, indicating a 12.5% reduction[22]. - The company spent $269,403,633.86 on purchasing goods and services in Q1 2024, down from $285,073,240.71 in Q1 2023, indicating cost control measures[25]. Market and Strategic Developments - The company has not reported any significant new product launches or technological advancements during this quarter[12]. - There are no updates on market expansion or mergers and acquisitions in the current report[12]. - The company has maintained its strategy without any new significant initiatives announced in this quarter[12]. - The company anticipates that the cumulative net profit for the year may still show a loss or a slight narrowing of the loss compared to the same period last year[14]. Shareholder Information - The top ten shareholders remain unchanged, with no participation in margin trading or securities lending activities reported[13].